Involvement of an NAD(P)H oxidase-like enzyme in superoxide anion and hydrogen peroxide generation by rat type II cells

Thorax

Volumn 52, Issue 5, 1997, Pages 465-471

  Van Klaveren, R J ^a   Roelant, C ^a   Boogaerts, M ^a   Demedts, M ^a   Nemery, B ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

alveolar macrophage; bacteria; protein kinase C

Indexed keywords

4 O METHYLPHORBOL 13 ACETATE 12 MYRISTATE; ARACHIDONIC ACID; HYDROGEN PEROXIDE; OXYGEN RADICAL; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS AUREUS;

EID: 0031008595     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.5.465     Document Type: Article

References (27)

1. Crapo JD, Young SL, Fram EK, Pinkerton KE, Barry BE, Crapo R. Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am Rev Respir Dis 1983;128:S42 8.
2. Finkelstein JN. Physiologic and toxicologic responses of alveolar type II cells. Toxicology 1990;60:41 52.
3. 1-proteinase inhibitor by alveolar epithelial type II cells. J Appl Physiol 1993;75:2376 82.
4. Kinnula VL, Chang LY, Ho YS, Crapo JD. Hydrogen peroxide release from alveolar macrophages and alveolar type II cells during adaptation to hyperoxia in vivo. Exp Lung Res 1992;18:655 73.
5. Kinnula VL, Everitt JI, Whorton AR, Crapo JD. Hydrogen peroxide production by freshly isolated alveolar type II cells, alveolar macrophages and cultured endothelial cells. Am J Physiol 1991;261:L84 91.
6. Punjabi CJ, Laskin JD, Pendino KJ, Goller NL, Durham SK, Laskin DL. Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant. Am J Respir Cell Mol Biol 1994;11:165 72.
7. Umeki S. Activation factors of neutrophil NADPH oxidase complex. Minireview. Life Sci 1994;55:1 13.
8. Bellavite P. The superoxide-forming enzymatic system of phagocytes. Free Rad Biol Met 1988;4:225-61.
9. Zulueta JJ, Yu FS, Hertig IA, Thannickal VJ. Release of hydrogen peroxide in response to hypoxia-reoxygenation: role of an KAD(P)H oxidase-like enzyme in endothelial cell plasma membrane. Am J Respir Cell Mol Biol 1995; 12:41 9.
10. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141 8.
11. Dupuy C, Virion A, Ohayon R, Kaniewski J, Dème D, Pommier J. Mechanism of hydrogen peroxide formation catalyzed by NADPH oxidase in thyroid membrane. J Biol Chem 1991;266:3739-43.
12. Richards RJ, Davies N, Atkins J, Oreffo VIC. Isolation, biochemical characterization and culture of lung epithelial type II cells of the rat. Lung 1987;165:143-58.
13. Hoet PHM, Lewis CPL, Demedts M, Nemery B. Putrescine and paraquat uptake in human lung slices and isolated type II pneumocytes. Biochem Pharmacol 1994;48:517-24.
14. Allen RC. Phagocyte leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol 1986;133:449 93.
15. Bradford MM. Rapid and sensitive method for the quantitution of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-54.
16. Patriarca P, Cramer R, Moncalvo S, Rossi T, Romeo D. Enzymatic basis of metabolic stimulation in leucocytes during phagocytosis: the role of activated NADPH oxidase. Arch Biochem Biophys 1971;145:255-62.
17. Egan TM, Minta JO, Scrimgeour KG, Cooper JE. Captopril - a potential free radical scavenger: inhibition of PMN NADPH oxidase. Clin Invest Med 1988;11:351-6.
18. Gabig TG, Lefker BA. NADPH oxidase from polymorphonuclear cells. Methods Enzymol 1986;132:355-64.
19. Jones OTG, Hancock JT. Assays of plasma membrane NADPH oxidase. Methods Enzymol 1994;233:222-9.
20. Tosi MF, Hamedani A. A rapid specific assay for superoxide release from phagocytes in small volumes of whole blood. Am J Clin Pathol 1992;97:566-73.
21. Vilim V, Wilhelm J. What do we measure by a luminol-dependent chemiluminescence of phagocytes? Free Rad Biol Med 1989;6:623-9.
22. Kinnula VL, Chang LY, Ho YS, Crapo JD. Hydrogen peroxide release from alveolar macrophages and alveolar type II cells during adaptation to hyperoxia in vivo. Exp Lung Res 1992;18:655-73.
23. Brunori M, Rotilio G. Biochemistry of oxygen radical species. Methods Enzymol 1984;105:22-34.
24. Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzalez JA. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 1991;5:98-103.
25. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakanes M, et al. The bisindolyl-maleimide GF109203x is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991;266:15771-81.
26. Miesel R, Sanocka D, Kurpisz M, Kroger H. Anti-inflammatory effects of NADPH oxidase inhibitors. Inflammation 1995;19:347-62.
27. Fukuto JM, Chaudhuri G. Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition. Annu Rev Pharmacol Toxicol 1995;35:165-94.